Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie Weingart, Eric H. Raabe, Jacquelyn J. Roth et al.|Oncotarget|2014Cited by 85
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesClaire Sun, Chris Jones, Paul Daniel et al.|Cancer Cell|2023Cited by 69
The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine gliomaHiroaki Miyahara, Eric H. Raabe, Sridevi Yadavilli et al.|Cancer Letters|2017Cited by 68
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumorElizabeth Alva, Ashley Margol, Jeffrey Rubens et al.|Neoplasia|2023Cited by 36
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-NorleucineSabrina Wang, Jeffrey Rubens, Brad Poore et al.|Clinical Cancer Research|2019Cited by 34